OSRH Q4 2024 Earnings — OSR Holdings, Inc. Revenue & Financial Results | Market Cap Arena

OSRHOSR Holdings, Inc.

$13M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.45

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$502,906

Free Cash Flow

-$502,906

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2M

Total Liabilities

$9M

Stockholders' Equity

-$6M

Cash & Equivalents

$66,135

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$2M	-$862,000	-148.7%
Net Income	-$2M	-$86,172	-2246.8%